Hims & Hers launches GLP-1 drug shortage tracker
Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...
Yahoo18h
The Woman’s World Expert-Reviewed Glossary of GLP-1, Semaglutide and Telehealth
The effects last only for a few hours. Examples include exenatide and lixisenatide. Ozempic: Novo Nordisk’s name-brand ...
Hims & Hers launches GLP-1 tracker in response to FDA's shortage decision
Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...
Why maker of ‘magic’ weight-loss drug semaglutide wants copies banned
US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...
What's Going On With Hims & Hers Health Stock On Wednesday?
Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing ...
Yahoo Finance14h
Hims & Hers launches GLP-1 shortage tracker in its battle with the FDA
No adequate supply? Semaglutide (GLP-1) weight-loss drug Wegovy, made by pharmaceutical company Novo Nordisk. (Photo: James ...
pharmaphorum11h
Amgen plays down safety concern with obesity candidate
Amgen has rebuffed claims made by an analyst suggesting that its obesity drug MariTide is associated with reductions in bone ...
Hosted on MSN23h
Ozempic on steroids? Successor that could cut down weight in half the time coming soon
On a call with investors last week, Danish drugmaker Novo Nordisk shared some teasers about CagriSema, the next generation of ...
Future Market Insights1h
Global Weight Loss and Obesity Management Market Poised for Remarkable Growth, Projected to Reach USD 48,396 Million by 2034
The global weight loss and obesity management market is set to experience remarkable expansion in the coming decade. With new ...
FierceBiotech11h
Gura's weekly amylin obesity asset well-tolerated, tied to weight loss in phase 1 trial
GUBamy is part of the investigational amylin field, a burgeoning landscape that includes Novo Nordisk’s CagriSema, a ...
Hosted on MSN12h
Patients Reveal Another "Nightmare" Ozempic Side Effect
Better known by Novo Nordisk's brand names Ozempic and Wegovy (the former of which is indicated only for type 2 diabetes), ...
Finanznachrichten13h
Lexaria Bioscience Corp.: Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss
KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces it has received lead ...